| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 05/29/2001 | US6238664 Process for stabilizing proteins |
| 05/29/2001 | US6238662 The use of these in the investigation, diagnosis and treatment of subjects suspected of or suffering from alpha-l-iduronidase deficiency. |
| 05/29/2001 | US6238661 Use of bacterial phage associated lysing enzymes for treating various illnesses |
| 05/29/2001 | US6238658 Oxidizing agent containing several components and process for permanently reshaping the hair using this agent |
| 05/29/2001 | CA2225450C Interleukin-1 receptor-associated protein kinase and assays |
| 05/29/2001 | CA2171611C Analog of haemophilus hin47 with reduced protease activity |
| 05/29/2001 | CA2043762C Lipopeptide deacylase |
| 05/29/2001 | CA2034881C Factor x-laci hybrid protein |
| 05/29/2001 | CA2031286C Methods for the biological inactivation of nucleic acids |
| 05/25/2001 | WO2001037194A2 Crystallizable compositions comprising a caspase-7 |
| 05/25/2001 | WO2001036659A2 Selectable cell surface marker genes |
| 05/25/2001 | WO2001036656A2 A complex between hyaluronic acid and a biomolecule and its use |
| 05/25/2001 | WO2001036654A1 Biocatalytic epoxidation of vinylaromatic compounds |
| 05/25/2001 | WO2001036645A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036638A2 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | WO2001036632A2 Variants of alternative splicing |
| 05/25/2001 | WO2001036611A1 Process for the production of a reversibly inactive acidified plasmin composition |
| 05/25/2001 | WO2001036610A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | WO2001036609A1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 05/25/2001 | WO2001036608A1 Reversibly inactivated acidified plasmin |
| 05/25/2001 | WO2001036607A1 Site-directed mutagenesis of escherichia coli phytase |
| 05/25/2001 | WO2001036606A2 Protoporphyrinogen ix oxidase and the use thereof |
| 05/25/2001 | WO2001036605A2 2786, a human aminopeptidase |
| 05/25/2001 | WO2001036604A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 05/25/2001 | WO2001036603A2 Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
| 05/25/2001 | WO2001036602A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 05/25/2001 | WO2001036600A1 MOUSE ASPARTIC SECRETASE-2 (mASP-2) |
| 05/25/2001 | WO2001036592A1 Sterilized microbial cells |
| 05/25/2001 | WO2001036586A2 Aspegillus niger beta-glucosidase gene, protein and uses thereof |
| 05/25/2001 | WO2001036474A2 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | WO2001036466A2 Educational kit and method using colipase-like protein-1 |
| 05/25/2001 | WO2001036464A2 SUNFLOWER RhoGAP, LOX, ADH, AND SCIP-1 POLYNUCLEOTIDES AND METHODS OF USE |
| 05/25/2001 | WO2001036462A2 Protein c derivatives |
| 05/25/2001 | WO2001035810A2 Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| 05/25/2001 | WO2001035750A1 Methods for using lactonohydrolases in baking |
| 05/25/2001 | WO2001035748A1 Bifunctional molecules having modulated pharmacokinetic properties and therapies based thereon |
| 05/25/2001 | WO2001035735A1 Production of ungulates, preferably bovines that produce human immunoglobulins |
| 05/25/2001 | WO2001023535A3 Hydantoin-racemase |
| 05/25/2001 | WO2001004141A3 Seripancrin |
| 05/25/2001 | WO2000064469A3 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 05/25/2001 | WO2000047750B1 Metalloproteases of the neprilysin family |
| 05/25/2001 | CA2392076A1 Human enzymes of the metalloprotease family |
| 05/25/2001 | CA2392065A1 Sunflower rhogap, lox, adh, and scip-1 polynucleotides and methods of use |
| 05/25/2001 | CA2392044A1 Educational kit and method using colipase-like protein-1 |
| 05/25/2001 | CA2391908A1 Novel polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391885A1 Polypeptides and nucleic acids encoding same |
| 05/25/2001 | CA2391739A1 Site-directed mutagenesis of escherichia coli phytase |
| 05/25/2001 | CA2391651A1 Protein c derivatives |
| 05/25/2001 | CA2391593A1 Selectable cell surface marker genes |
| 05/25/2001 | CA2390882A1 Cancer immunotherapy and diagnosis using cytochrome p450 1b1 |
| 05/25/2001 | CA2389569A1 Crystallizable compositions comprising a caspase-7 |
| 05/25/2001 | CA2389487A1 Process for the production of a reversibly inactive acidified plasmin composition |
| 05/25/2001 | CA2389430A1 Srik a novel cell cycle protein associated with rip3 |
| 05/25/2001 | CA2362913A1 Methods for using lactonohydrolases in baking |
| 05/25/2001 | CA2324496A1 New nucleotide sequences coding for the genes succ and sucd |
| 05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
| 05/24/2001 | US20010001661 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/24/2001 | CA2326758A1 Process for the preparation of microencapsulated enzymes |
| 05/23/2001 | EP1101823A2 Process for the preparation of indigo derivatives and dyes for ceratinous fibers containing the same |
| 05/23/2001 | EP1101821A1 Novel protein and its dna |
| 05/23/2001 | EP1101412A2 Use of a high-ester pectin in acidic, protein-containing foodstuffs |
| 05/23/2001 | EP1100949A1 Fusion products containing insoluble proteinaceous tag |
| 05/23/2001 | EP1100941A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 05/23/2001 | EP1100940A2 Genes involved in tolerance to environmental stress |
| 05/23/2001 | EP1100939A1 Nucleic acid molecule coding for beta-amylase, plants synthesizing a modified starch, method of production and applications |
| 05/23/2001 | EP1100938A2 Modification of starch biosynthetic enzyme gene expression to produce starches in grain crops |
| 05/23/2001 | EP1100937A1 Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch |
| 05/23/2001 | EP1100936A1 Methods and means to modulate programmed cell death in eukaryotic cells |
| 05/23/2001 | EP1100935A1 Mutant e.coli strains, and their use for producing recombinant polypeptides |
| 05/23/2001 | EP1100933A1 New caspase homologue |
| 05/23/2001 | EP1100932A2 Method for autoactivation of procaspase 8 |
| 05/23/2001 | EP1100931A2 Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch |
| 05/23/2001 | EP1100930A1 Method to alter the fatty acid metabolism in plants |
| 05/23/2001 | EP1100929A1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 05/23/2001 | EP1100928A2 Enzymes for biopolymer production |
| 05/23/2001 | EP1100927A2 Methods for making polyketides using altered pks |
| 05/23/2001 | EP1100923A2 Thermostable in vitro complex with polymerase activity |
| 05/23/2001 | EP1100915A2 Fibrous proteins and the production thereof |
| 05/23/2001 | EP1100912A1 Method for screening of modulators of calcineurin activity |
| 05/23/2001 | EP1100904A2 Phosphorylation effectors |
| 05/23/2001 | EP1100901A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 05/23/2001 | EP1100891A2 Expression of functional eukaryotic proteins |
| 05/23/2001 | EP1100883A2 Map kinase phosphatase mutant |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100881A1 Recombinant dehydrodiconiferyl alcohol benzylic ether reductase, and methods of use |
| 05/23/2001 | EP1100880A2 Urate oxidase |
| 05/23/2001 | EP1100879A1 Pneumococcal nrdg protein |
| 05/23/2001 | EP1100814A2 Inhibitors of urokinase and blood vessel formation |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100782A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
| 05/23/2001 | EP1100542A2 Peg-urate oxidase conjugates and use thereof |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100513A1 Autoinducer synthase modulating compounds and uses therefor |
| 05/23/2001 | EP1100510A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 05/23/2001 | EP1100310A1 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
| 05/23/2001 | EP1100308A1 Copper transporter in ethylene signaling pathway |
| 05/23/2001 | EP0699248B1 Methods for treating non-cotton-containing cellulosic fabrics with cellulase |
| 05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
| 05/23/2001 | DE19955605A1 Cytochrome P450 monooxygenase for oxidizing organic compounds, useful especially for converting indole to indigo, has wide substrate range |
| 05/23/2001 | DE19950589A1 Elongasepromotoren für gewebespezifische Expression von Transgenen in Pflanzen Elongasepromotoren for tissue-specific expression of transgenes in plants |